The Catalent Applied Drug Delivery Institute, Columbia Lab-to-Market Accelerator Network and the Translational Therapeutics Accelerator (TRx) will be organizing an upcoming event focused on key considerations for transitioning a molecule from discovery to phase 1 readiness. The agenda is designed to be highly interactive and features Dr. Cornell Stamoran, Founder, Catalent Institute, Mike Rea, CEO, IDEA Pharma, and Jim Spavins, former Head of Pfizer's Global PTx Pharmaceutical Sciences group along with leading scientific and pharmaceutical experts. By attending this event, you will learn about API and formulation development, pharmacokinetics, quality and regulatory requirements, and incorporation of patient focus design principles.
50 Haven Avenue
New York, NY 10032